American Shared Hospital Services Reports Third Quarter 2025 Financial Results GlobeNewswire November 13, 2025 Third Quarter Revenue Increased 2.5% Period over Period with 42.3% EBITDA Growth Revenue for the First Nine Months Increased 5.6% Year Over Year Signs Existing Health System to 10 Year Extension and an Upgrade to their Gamma Knife System Conference Call […]
New Fig Data: 94% of Canadians Say Talking About Money Struggles Should Be More Acceptable New data from Fig highlights how debt and financial stress are deeply tied to emotion, shame and the need for open dialogue GlobeNewswire November 13, 2025 TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) — A new national survey commissioned by Fig,
Marigold PR Launches PRplus for the AI Era Canadian PR agency positions B2B brands to compete as AI reshapes online discovery GlobeNewswire November 13, 2025 Toronto, Ontario, Nov. 13, 2025 (GLOBE NEWSWIRE) — As artificial intelligence (AI) becomes the default for online discovery, B2B businesses that are not investing in public relations risk disappearing from
CHARM Therapeutics advances CHM-029, a next-generation menin inhibitor designed to overcome resistance mutations, as its first clinical candidate for acute myeloid leukaemia (AML) GlobeNewswire November 13, 2025 PRESS RELEASE AI-discovered candidate CHM-029 demonstrates robust, dose-dependent tumor regression in pre-clinical AML models and retains potency against all known resistance mutations First-in-human trials expected to begin in
Sitryx to participate in upcoming healthcare investor conferences GlobeNewswire November 13, 2025 Oxford, UK and Boston, MA – November 13, 2025 – Sitryx Therapeutics (“the Company”), a clinical-stage biopharmaceutical company developing novel oral therapies to restore immune balance in autoimmune and inflammatory disease, today announced that management will be participating in three upcoming healthcare conferences:
IonQ, AMD and Qualcomm Ventures Join Classiq Strategic Up-Round The additional tens of millions in strategic funding bring Classiq's total funding to over $200 million, reflecting confidence from global technology and finance leaders in its enterprise-grade quantum software platform GlobeNewswire November 13, 2025 TEL AVIV, Israel, Nov. 13, 2025 (GLOBE NEWSWIRE) — Classiq, the global
Aebi Schmidt Group achieves significant step-up in profitability following the integration of the Shyft Group; strong order momentum and continued backlog growth GlobeNewswire November 13, 2025 Very strong order momentum, with third quarter order intake up 33% year-over-year Order backlog increased by another 6% since June 2025, supporting 2026 growth ambitions Group net sales of
Siris Announces Transition of Managing Partner Peter Berger to Chairman GlobeNewswire November 13, 2025 WEST PALM BEACH, Fla., Nov. 13, 2025 (GLOBE NEWSWIRE) — Siris, a leading private equity firm targeting growth-oriented, tech-enabled service companies, today announced the long-planned transition of Co-Founder Peter Berger from Managing Partner to Chairman. Siris' remaining senior investment and operational
Evoke Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update GlobeNewswire November 13, 2025 Entered into an Agreement to be acquired by QOL Medical Net product sales for the third quarter of 2025 reached $4.3 million; up 61% year-over-year Gimoti patent life for Gimoti extended through November 2038 SOLANA BEACH, Calif., Nov. 13,
Completed enrollment in Part B of SIGNAL-AA Phase 2a clinical trial and increased trial size to 33 patients based on patient demand;topline data readout expected in mid-2026 — Dosing of patients in Part A open-label extension (OLE) ongoing — Cash and cash equivalents of$49.0 millionas ofSeptember 30, 2025 expected to provide financial runway into 2027